Use of a primary prevention totally subcutaneous defibrillator in hypertrophic cardiomyopathy

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 5, 2010, Pages 560-561

  Baez Escudero, Jose L ^a   Beshai, John F ^a   Burke, Martin C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiomyopathy hypertrophic; Death sudden; Defibrillation electric; Prevention; Primary; Subcutaneous tissue

Indexed keywords

ADULT; ARTIFICIAL HEART PACEMAKER; CASE REPORT; DEFIBRILLATOR; HEART CONDUCTION; HEART DEATH; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; MALE; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; SUDDEN DEATH; VASCULAR ACCESS; ARTICLE; CARDIOVERSION; HEART RATE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROGNOSIS;

EID: 78049496234     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.958561     Document Type: Note

References (1)

1. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36-44.